OR WAIT null SECS
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
Siemens enters agreement with Pfizer to commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.
Siemens has entered into an agreement with Pfizer to design, develop, and commercialize diagnostic tests for therapeutic products across Pfizer's pipeline. Under the agreement, Siemens will be one of Pfizer's collaboration partners to develop and provide in vitro diagnostic tests for use in clinical studies.
The partnership will help Siemens' in providing clinical diagnostic solutions for hospital and reference laboratories, specialty laboratories, and point-of-care settings (including clinics and physician offices) to help enable diagnostics development.
Source: Siemens